Laboratory values for children with newly diagnosed inflammatory bowel disease

Area of Science:

• Pediatric Gastroenterology
• Inflammatory Bowel Disease (IBD) Diagnostics
• Clinical Laboratory Science

Background:

• Inflammatory bowel disease (IBD) encompasses chronic conditions like Crohn's disease and ulcerative colitis.
• Accurate and timely diagnosis in pediatric patients is crucial for effective management.
• The role of routine laboratory screening in the initial diagnosis of pediatric IBD requires further clarification.

Purpose of the Study:

• To evaluate the frequency of normal results across common laboratory tests at the time of diagnosis in children with IBD.
• To assess the utility of hemoglobin, platelet count, albumin, and erythrocyte sedimentation rate in diagnosing pediatric IBD.

Main Methods:

• Prospective enrollment of 526 children with newly diagnosed inflammatory bowel disease (IBD) across 18 US/Canadian centers.
• Analysis of baseline laboratory values including hemoglobin, platelet count, albumin, and erythrocyte sedimentation rate.
• Categorization of disease severity using physician global assessment.

Main Results:

• A significant proportion of children with mild IBD presented with normal results for all four investigated laboratory values (21% for Crohn disease, 54% for ulcerative colitis).
• Conversely, only a small percentage of children with moderate to severe IBD had normal results across all tests (3.8% for Crohn disease, 4.3% for ulcerative colitis).
• Erythrocyte sedimentation rate was the least likely to be normal, with 26% of all pediatric IBD patients showing normal levels, including 18% with moderate/severe disease.

Conclusions:

• Normal screening laboratory studies in children do not exclude a diagnosis of inflammatory bowel disease (IBD).
• Clinicians should maintain a high index of suspicion for IBD even when initial laboratory results are unremarkable.
• Laboratory test abnormalities correlate with disease severity, particularly in ulcerative colitis.